 |
|
|
 Hot Stock to Watch |
Company: Medical Marijuana Inc. (Pink Sheets: MJNA) |
Last:
Price: 0.227
Change (%): + 0.0325 (16.71)
Volume: 40,026,784 |
 |
Medical Marijuana Inc., 4th Quarter 2013 Corporate Update: HempMedsPX Has 500% Revenue Increase - Division and Corporate Holdings Update
Company's Divisions' Growth Includes Investing in Local Manufacturers, Distributors, Brands and Dot Coms; Public Awareness of Industrial Hemp-Based Cannabidiol (CBD) Products Created With Mainstream News Media Coverage and Community Outreach
SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) - Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately 8.07 million dollars. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or 1.06 million dollars, with a gross income of over 1.31 million dollars. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.
Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports.
CanChew Biotechnologies - In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
